
Medicare drug price negotiations lowered out-of-pocket costs for some beneficiaries, but those reaching the annual Part D cap saw no direct savings.
Supplements and Featured Publications
over 24 years ago
Introductionover 24 years ago
Migraine: Diagnosis, Management, and New Treatment Options





